RDRaed A. Dweik

Raed A. Dweik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Raed A. Dweik has a total of 548 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transhepatic Gradients Reveal Selective Hepatic Processing Defects With Systemic Consequences in Cirrhosis

    by Graham Stockdale, Adam Fawaz, Marla Bashour, Kulwant S. Aulak, Maria Del Pilar Bayona Molano, Baljendra Kapoor, Raed A. Dweik, Adriano R. Tonelli

    Background/Objectives: The cirrhotic liver's metabolic capacity remains incompletely characterized, particularly its role in shaping portal metabolite signals that reach the systemic circulation. Transjugular intrahepatic portosystemic shunt (TIPS) placement allows paired portal and right atrial sampling to estimate transhepatic gradients. Methods: We performed global metabolomic profiling on paired portal vein and right atrial samples from 11 patients with cirrhosis during TIPS placement, with right atrial sampling repeated immediately after shunt creation. Pre‐TIPS right atrial profiles were compared with peripheral venous samples from 15 healthy controls. For each metabolite, we calculated a transhepatic gradient (portal to pre‐TIPS right atrial relative abundance) and a post‐TIPS change, and used directional concordance between the two as indirect evidence of hepatic processing. Of 676 metabolites, 612 had sufficient paired data. Results: Of 676 metabolites, 305 (45.1%) differed between cirrhotic patients and controls at q < 0.1, with 170 elevated and 135 depleted. Among 612 metabolites with paired data, 124 changed after TIPS at p < 0.05, and 113 (91.1%) were directionally concordant with their pre‐TIPS transhepatic gradients. Fifty of these showed impaired hepatic extraction and 63 showed a hepatic dilution pattern. Conclusions: The cirrhotic liver retains measurable but selective metabolite processing, with disruption that may carry consequences beyond the liver itself. Cirrhosis is better understood as a disorder of hepatic signaling with systemic consequences than as uniform hepatic failure.

  • Open Access

    Endotypes of Vascular Health Predict Transplantation‐Free Survival in Pulmonary Hypertension

    by Samar Farha, Bo Hu, Ruoying Chen, John Barnard, Suzy Comhair, Gustavo Heresi, Joseph Parambil, Adriano Tonelli, Gerald Beck, Erika Berman‐Rosenzweig, et al.

    Background: The current classification of pulmonary hypertension (PH), based largely on expert opinion, has limitations in prognostication and guiding therapies. We hypothesize that novel PH clusters that predict survival will reveal mechanistic phenotypes associated with biomarkers of vascular health across all PH groups. Methods: We first identify novel PH clinical clusters by performing unsupervised clustering analysis on the CC‐PH (Cleveland Clinic PH) registry (N=1529). We develop classification models to predict the new PH clusters and then apply them to the multicenter PVDOMICS (Pulmonary Vascular Diseases Phenomics) cohort (N=853) for validation. We compare transplantation‐free survival across the new PH clusters. We quantify metabolites of the arginine‐nitric oxide pathway and D‐dimer levels and calculate global arginine bioavailability (arginine/[ornithine+citrulline]) to assess endothelial function and activation in the new clusters and link these biomarkers to clinical outcomes. Results: Clustering analysis identify 3 clear clusters in CC ‐ PH that are validated in PVDOMICS and outperform conventional classifications in predicting transplantation‐free survival. The phenotype associated with the worst survival is characterized by reduced lung diffusion capacity, decreased arginine bioavailability and nitrate levels, and elevated D‐dimer levels, consistent with loss of pulmonary microcirculation and endothelial dysfunction. Conclusions: We identify new informative PH phenotypes associated with mortality and defined by biomarkers of endothelial function and activation. Loss of endothelial health and pronounced pulmonary vascular rarefication contribute more substantially to mortality across the spectrum of PH than right heart function. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02980887.


  • Open Access

    CD248 activates TGF-β receptor I to promote vascular remodeling in pulmonary arterial hypertension

    by Luke I Jones, Hannah J McIntire-Ray, Angela N Morales, Shia Vang, Meghan J Hirsch, Andres J Gonzalez Coba, Emma Lea Matthews, Katherine L Adriatico, Nicholas P Harris, Iram Zafar, et al.

    I. Background: Pulmonary arterial hypertension (PAH) is a debilitating cardiopulmonary disease characterized by progressive remodeling of the pulmonary vasculature. Pathologic transforming growth factor-β (TGF-β) signaling is an essential driver of vascular remodeling in PAH. While global inhibitors of TGF-β exist, their clinical application is limited by systemic adverse effects. Therefore, a critically unmet need in PAH is to identify pulmonary vascular-specific regulators of the TGF-β axis, which would selectively enhance clinical efficacy while minimizing adverse effects. As the clinical care of PAH largely promotes vasodilation, and only one FDA-approved agent targets vascular remodeling, this study aimed to identify selective, therapeutically targetable regulators of the TGF-β axis in the PAH pulmonary vasculature. Methods: CD248 was identified via liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomics in human lungs. CD248 levels were assessed across human, rat, and mouse lung tissues using western blotting, RTqPCR, and/or immunofluorescence techniques. CD248-null (CD248 -/- ) mice were used to study the contribution of CD248 to hypoxia-sugen (H/S)-induced PAH. The mechanistic role of CD248 in PAH vascular remodeling and TGF-β signaling was assessed by genetic (siRNA knockdown; overexpression) and pharmacologic (Ontuxizumab) manipulation of primary human pulmonary vascular cells. Results: LC-MS/MS proteomics coupled with pathway enrichment analysis of human lung tissue identified CD248 as a putative mediator of vascular remodeling that is elevated in PAH lungs. CD248 was elevated in PAH pulmonary artery smooth muscle cells (PASMCs) across human, rat, and mouse lung tissue. CD248 -/- mice were protected from H/S-induced elevations in right ventricular (RV) systolic pressure (RVSP), RV hypertrophy, and pulmonary artery muscularization. CD248 knock-down reduced cell proliferation and migration of primary PAH PASMCs. CD248 was essential for phospho-activation of TGF-β receptor I (TβRI) at S165 and canonical phosphorylation of SMAD3 at S423/425. CD248 loss blunted TGF-β-induced gene expression (FN1, Col1α1, α-SMA) and activated expression of the vasoprotective matrix metalloprotease, MMP-8. Mechanistically, CD248 interacted with and enhanced de novo phosphorylation and stability of TβRI, blocking its ubiquitin-mediated proteasomal degradation. Ontuxizumab promoted TβRI instability and attenuated the production of FN1, Col1α1, and α-SMA in primary PAH PASMCs. Conclusions: This work identifies CD248 as a previously unrecognized co-activator of TβRI in PAH. As CD248 is largely quiescent in most adult tissues yet pathologically upregulated in the PAH pulmonary vasculature, this study supports the potential of anti-CD248 therapy as a novel pulmonary vascular-specific alternative to systemic TGF-β inhibition.

  • Detection of Clostridioides difficile infection by assessment of exhaled breath volatile organic compounds

    by Teny M John, Nabin K Shrestha, Leen Hasan, Kirk Pappan, Owen Birch, David Grove, Billy Boyle, Max Allsworth, Priyanka Shrestha, Gary W Procop, et al.

    Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired infective diarrhea. Current methods for diagnosing CDI have limitations; enzyme immunoassays for toxin have low sensitivity and Clostridioides difficile polymerase chain reaction cannot differentiate infection from colonization. An ideal diagnostic test that incorporates microbial factors, host factors, and host-microbe interaction might characterize true infection. Assessing volatile organic compounds (VOCs) in exhaled breath may be a useful test for identifying CDI. To identify a wide selection of VOCs in exhaled breath, we used thermal desorption-gas chromatography-mass spectrometry to study breath samples from 17 patients with CDI. Age- and sex-matched patients with diarrhea and negative C.difficile testing (no CDI) were used as controls. Of the 65 VOCs tested, 9 were used to build a quadratic discriminant model that showed a final cross-validated accuracy of 74%, a sensitivity of 71%, a specificity of 76%, and a receiver operating characteristic area under the curve of 0.72. If these findings are proven by larger studies, breath VOC analysis may be a helpful adjunctive diagnostic test for CDI.


  • Open Access

    Exhaled Breath Analysis Using Selected Ion Flow Tube Mass Spectrometry and Disease Severity in Heart Failure

    by Wai Hong Wilson Tang, Lily Tranchito, Chonyang Albert, Zeynep G. Gul, Frank S. Cikach, David Grove, Yuping Wu, Raed A. Dweik

    Exhaled breath volatile organic compounds (VOCs) are elevated in heart failure (HF). The ability of VOCs to predict long term cardiovascular mortality and morbidity has not been independently verified. In 55 patients admitted with acute decompensated heart failure (ADHF), we measured exhaled breath acetone and pentane levels upon admission and after 48 h of diuresis. In a separate cohort of 51 cardiac patients undergoing cardiopulmonary exercise testing (CPET), we measured exhaled breath acetone and pentane levels before and at peak exercise. In the ADHF cohort, admission acetone levels correlated with lower left ventricular ejection fraction (LVEF, r = −0.297, p = 0.035). Greater weight loss with diuretic therapy correlated with a greater reduction in both acetone levels (r = −0.398, p = 0.003) and pentane levels (r = −0.309, p = 0.021). In patients with above-median weight loss (≥4.5 kg), patients demonstrated significantly greater percentage reduction in acetone (59% reduction vs. 7% increase, p < 0.001) and pentane (23% reduction vs. 2% reduction, p = 0.008). In the CPET cohort, admission acetone and pentane levels correlated with higher VE/VCO2 (r = 0.39, p = 0.005), (r = 0.035, p = 0.014). However, there were no significant correlations between baseline or peak exercise acetone and pentane levels and peak VO2. In longitudinal follow-up with a median duration of 33 months, patients with elevated exhaled acetone and pentane levels experienced higher composite adverse events of death, ventricular assist device implantation, or orthotopic heart transplantation. In patients admitted with ADHF, higher exhaled breath acetone levels are associated with lower LVEF and poorer outcomes, and greater reductions in exhaled breath acetone and pentane tracked with greater weight loss. Exhaled acetone and pentane may be novel biomarkers in heart failure worthy of future investigation.


  • Open Access

    Breath Analysis in Children with Ketogenic Glycogen Storage Diseases

    by Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Xiaozhen Han, Xiaofeng Wang, David Grove, Adriano R. Tonelli, Raed A. Dweik, Laurie Minarich, Kadakkal Radhakrishnan, Naim Alkhouri

    (1) Background: The treatment goal of ketogenic glycogen storage diseases (GSDs) is appropriate control of hypoglycemia and other disturbances such as dyslipidemia. Monitoring and treatment of ketosis are known to improve outcomes. We used breath analysis to identify volatile organic compounds (VOCs) that correlate with serum ketones in order to provide a non-invasive method of monitoring ketosis. (2) Methods: Consecutive children with ketogenic GSDs were recruited from a single center during routine admission to monitor serum glucose and ketone levels. Five breath samples were collected from every patient at the same time of blood draws. SIFT-mass spectrometry was used to analyze breath samples. Univariate linear mixed-effects regression models for 22 known VOCs and either serum ketones or glucose were performed. (3) Results: Our cohort included 20 patients aged 5–15 years with a mean BMI of 20 kg/m2 (72% tile). Most patients had GSD type 0 (35%), while 25% had type IX. VOCs that showed a significant correlation with serum ketone levels included acetone (p < 0.0001), trimethylamine (p < 0.0001), pentane (p = 0.0001), 3-methylhexane (p = 0.0047), and carbon disulfide (p = 0.0499). No correlation was found between serum glucose and any VOC. (4) Conclusions: Breath analysis is a promising noninvasive tool that can be used to predict ketone serum levels in patients with GSD.

  • The breath print represents a novel biomarker of malnutrition in pulmonary arterial hypertension: A proof of concept study

    by Jacob T. Mey, Mary C. Rath, Kathleen McLaughlin, Marianne Galang, Kathryn Lynch, Jaime DiMattio, Hillary Nason, Shengping Yang, Celia A. Melillo, David E. Grove, et al.

    Background: The breath print is a quantitative measurement of molecules in exhaled breath and represents a new frontier for biomarker identification. It is unknown whether this state‐of‐the‐art, noninvasive method can detect malnutrition. We hypothesize that individuals with malnutrition will present with a distinguishable breath print.Methods: We conducted a retrospective chart review on patients with previously analyzed breath samples to identify malnutrition. Breath was analyzed by selected‐ion flow‐tube mass spectrometry. Registered dietitians conducted a retrospective chart review to collect malnutrition diagnoses and nutrition status indicators. Patients were categorized into one of four groups: pulmonary arterial hypertension (PAH), PAH with malnutrition (PAH‐Mal), control, and control with malnutrition (Control‐Mal), based on the malnutrition diagnosis present in the patient's chart. Principle component analysis was conducted to characterize the breath print. A logistic regression model with forward selection was used to detect the best breath predictor combination of malnutrition.Results: A total of 74 patients met inclusion criteria (PAH: 52; PAH‐Mal: 10; control: 10; Control‐Mal: 2). Levels of 1‐octene (PAH‐Mal, 5.1 ± 1.2; PAH, 12.5 ± 11.2; P = 0.005) and ammonia (PAH‐Mal, 14.6 ± 15.8; PAH, 56.2 ± 64.2; P = 0.013) were reduced in PAH‐Mal compared with PAH. The combination of 1‐octene (P = 0.010) and 3‐methylhexane (P = 0.045) distinguished malnutrition in PAH (receiver operating characteristic area under the curve: 0.8549).Conclusions: This proof of concept study provides the first evidence that the breath print is altered in malnutrition. Larger prospective studies are needed to validate these results and establish whether breath analysis may be a useful tool to screen for malnutrition in the clinical setting.


  • Open Access

    Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement

    by Andrea S. Gershon, Peter K. Lindenauer, Kevin C. Wilson, Louise Rose, Allan J. Walkey, Mohsen Sadatsafavi, Kevin J. Anstrom, David H. Au, Bruce G. Bender, M. Alan Brookhart, et al.

    Rationale: Decisions in medicine are made on the basis of knowledge and reasoning, often in shared conversations with patients and families in consideration of clinical practice guideline recommendations, individual preferences, and individual goals. Observational studies can provide valuable knowledge to inform guidelines, decisions, and policy. Objectives: The American Thoracic Society (ATS) created a multidisciplinary ad hoc committee to develop a research statement to clarify the role of observational studies—alongside randomized controlled trials (RCTs)—in informing clinical decisions in pulmonary, critical care, and sleep medicine. Methods: The committee examined the strengths of observational studies assessing causal effects, how they complement RCTs, factors that impact observational study quality, perceptions of observational research, and, finally, the practicalities of incorporating observational research into ATS clinical practice guidelines. Measurements and Main Results: There are strengths and weakness of observational studies as well as RCTs. Observational studies can provide evidence in representative and diverse patient populations. Quality observational studies should be sought in the development of ATS clinical practice guidelines, and medical decision-making in general, when 1) no RCTs are identified or RCTs are appraised as being of low- or very low-quality (replacement); 2) RCTs are of moderate quality because of indirectness, imprecision, or inconsistency, and observational studies mitigate the reason that RCT evidence was downgraded (complementary); or 3) RCTs do not provide evidence for outcomes that a guideline committee considers essential for decision-making (e.g., rare or long-term outcomes; “sequential”). Conclusions: Observational studies should be considered in developing clinical practice guidelines and in making clinical decisions.


  • Open Access

    Specific O-GlcNAc modification at Ser-615 modulates eNOS function

    by Kulwant S. Aulak, Jarrod W. Barnes, Liping Tian, Noel E. Mellor, Mohammad M. Haque, Belinda Willard, Ling Li, Suzy C. Comhair, Dennis J. Stuehr, Raed A. Dweik


  • Comparison of volatile organic compound profiles in exhaled breath versus plasma headspace in different diseases

    by David Grove, Galen Miller-Atkins, Celia Melillo, Florian Rieder, Satya Venkatesh Kurada, Daniel M Rotroff, Adriano R Tonelli, Raed A Dweik

    Breath analysis is the study of volatile organic compounds (VOC’s) in exhaled breath. This analysis provides information on the body’s condition. In this study we investigated the relationship between 22 VOC’s detected in exhaled breath and plasma headspace using a selected ion flow tube mass spectrometer (SYFT-MS). We compared pairs of exhaled breath and plasma samples from patients with pulmonary hypertension inflammatory bowel disease (IBD), and IBD patients after J-pouch surgery (pouch group). Half of the measured VOC’s from exhaled breath were significantly associated with the VOC’s from plasma headspace. Interestingly, six breath VOC’s (trimethyl amine (FDR p = 0.02), hydrogen sulfide (FDR p = 7.64 × 10 −30 ), ethanol (FDR p = 1.56 × 10 −4 ), dimethyl sulfide (FDR p = 5.70 × 10 −19 ), benzene (FDR p = 8.40 × 10 −27 ), and acetaldehyde (FDR p = 4.27 × 10 −17 )) and two plasma headspace VOC’s (1-Octene (FDR p = 0.02) and 2-propanol (FDR p = 2.47 × 10 −9 )) were able to differentiate between the three groups. Breath and plasma headspace share a similar signature with significant association in half of the measured VOCs. The disease discriminatory capacity of breath and plasma headspace appear to be different. Therefore, using the VOC’s print from both breath and plasma headspace may better help diagnose patients.